Stock markets stage strong rebound after four days of slump; Sensex rallies 599 pts

Stock markets rebounded from early lows to close higher on Friday, snapping the four-day losing streak on heavy value buying in banking and auto shares.

Stock markets rebounded from early lows to close higher on Friday, snapping the four-day losing streak on heavy value buying in banking and auto shares.

Also read:Sensex, Nifty open lower; IT stocks dragThe 30-share BSE Sensex climbed 599.34 points or 0.83 per cent to settle at 73,088.33. The index opened lower and tanked further 672.53 points or 0.92 per cent to hit a low of 71,816.46 in early trade. However, the index rebounded in the second half on value-buying in banking shares.

The NSE Nifty jumped 151.15 points or 0.69 per cent to close at 22,147. The broader index dropped to a low of 21,777.65 in early trade before paring its losses to end in the green.

From the Sensex basket, Bajaj Finance, Mahindra & Mahindra, HDFC Bank, JSW Steel, Maruti, Wipro, Bharti Airtel, Bajaj Finserv, ICICI Bank and ITC were the major gainers.

Nestle India, HCL Technologies, Larsen & Toubro, Tata Consultancy Services, Tata Motors and Infosys were among the laggards.

Infosys declined nearly 1 per cent after the company's revenue growth guidance for FY25 failed to meet market expectations.

In Asian markets, Seoul, Tokyo, Shanghai and Hong Kong settled in the negative territory.

European markets were trading in the red. Wall Street ended mostly lower on Thursday.

Global oil benchmark Brent crude climbed 0.55 per cent to $87.62 a barrel.

Foreign institutional investors (FIIs) offloaded equities worth ₹4,260.33 crore on Thursday, according to exchange data.

"Despite global weakness, Indian markets staged a strong recovery driven by large-cap stocks, buoyed by the expectation of limited prospects of escalation following Israel's action against Iran. However, fragility persists with elevated oil prices, posing inflation risks," said Vinod Nair, Head of Research, Geojit Financial Services.

Meanwhile, the 2024 Lok Sabha polls kicked off on Friday with the beginning of polling for the first phase.

Also read:Markets face heavy fluctuations; settle lower taking downtrend to fourth dayThe BSE benchmark tanked 454.69 points or 0.62 per cent to settle at 72,488.99 on Thursday. The NSE Nifty declined 152.05 points or 0.69 per cent to 21,995.85.

Like (0)
Previous April 19, 2024 7:39 pm
Next April 19, 2024 7:39 pm

Related posts

  • Techno Electric & Engineering secures new orders for ₹4,063 crore; stock surges 5%

    Techno Electric & Engineering has bagged new orders for ₹4,063 crore. The stock surged 5.22 per cent on the NSE as of 1.21 pm to trade at ₹1,020.

    US stock market 2 days ago
  • Comments: Northbound funds bought 349 million yuan in net, including 921 million yuan in Shanghai-Hong Kong Stock Connect net purchases

    According to news on April 25, northbound funds bought 349 million yuan in net throughout the day, of which 921 million yuan was bought in the Shanghai Stock Connect and 572 million yuan was sold in the Shenzhen Stock Connect.

    US stock market 6 days ago
  • Central Shopping Mall (600280.SH): Net profit in the first quarter was 6.2257 million yuan

    Gelonghui April 25 | Central Shopping Mall (600280.SH) released its first quarter report for 2024. During the reporting period, the company\’s operating income was 633 million yuan, a year-on-year decrease of 0.71%; the net profit attributable to shareholders of the listed company was 6.2257 million yuan; The net profit after deducting non-recurring gains and losses for shareholders of listed companies is 6.8092 million yuan; basic earnings per share is 0.006 yuan per share.

    US stock market 6 days ago
  • Bonda Asia: U.S. dollar rebounds, oil prices fall, U.S. dollar and Canadian dollar close slightly higher

    On April 25, Quincy Krosby, chief global strategist at LPL Financial, said: “When interest rates start to climb, adjustments have to be made. \”The calculus has changed, so the question is, if interest rates stay higher for longer, will we have a problem?\” ” Recent statements from Fed Chairman Jerome Powell and other policymakers have solidified the view that interest rates will not be cut in the coming months. In fact, there is even talk of another rate hike or two in the future if inflation does not ease further. That leaves many questions: when exactly will monetary policy ease, and what impact will the central bank\’s unchanged stance have on financial markets and the economy as a whole. Krosby said some answers will soon be revealed as the current earnings season heats up. Company executives will provide key details beyond sales and profits, including the impact of interest rates on margins and consumer behavior. He said: \”If there is any indication that businesses are going to have to start cutting costs, causing problems in the job market, then that\’s…

    US stock market 6 days ago
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market 6 days ago
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market 6 days ago